(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual revenue growth rate of 27.52% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.49%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.06%.
Rapid Micro Biosystems's revenue in 2026 is $30,523,000.On average, 6 Wall Street analysts forecast RPID's revenue for 2026 to be $1,814,033,531, with the lowest RPID revenue forecast at $1,728,756,935, and the highest RPID revenue forecast at $1,884,816,651. On average, 4 Wall Street analysts forecast RPID's revenue for 2027 to be $2,289,836,159, with the lowest RPID revenue forecast at $2,180,492,416, and the highest RPID revenue forecast at $2,378,126,689.
In 2028, RPID is forecast to generate $2,816,521,080 in revenue, with the lowest revenue forecast at $2,706,069,273 and the highest revenue forecast at $2,899,359,935.